RPL39
Large ribosomal subunit protein eL39
Also known as: L39, RL39_HUMAN, RPL39P42
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62891
- Gene
- RPL39
- Ensembl
- ENSG00000198918
- Chromosome
- X
- Canonical length
- 51 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
OverviewNCBI Gene
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the S39E family of ribosomal proteins. It is located in the cytoplasm. In rat, the protein is the smallest, and one of the most basic, proteins of the ribosome. This gene is co-transcribed with the U69 small nucleolar RNA gene, which is located in its second intron. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
51 residues, UniProt reviewed canonical sequence.
>P62891|RPL39
1 MSSHKTFRIK RFLAKKQKQN RPIPQWIRMK TGNKIRYNSK RRHWRRTKLG LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL39 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 5,244 nTPM
Expression across tissuesHPA
Tissue
- ovary: 5,244 nTPM
- breast: 4,460 nTPM
- bone marrow: 4,176 nTPM
- skin: 3,788 nTPM
- pancreas: 3,259 nTPM
- tonsil: 2,995 nTPM
Single-cell type
- gastric chief cells: 4,018 nCPM
- parietal cells: 3,732 nCPM
- mucous neck cells: 2,690 nCPM
- breast secretory cells: 2,033 nCPM
- enteric stem cells: 1,879 nCPM
- paneth cells: 1,559 nCPM
Immune cell
- total PBMC: 6,407 nTPM
- naive CD4 T-cell: 4,618 nTPM
- memory B-cell: 4,614 nTPM
- naive B-cell: 4,101 nTPM
- memory CD4 T-cell: 4,035 nTPM
- naive CD8 T-cell: 3,739 nTPM
Brain region
- spinal cord: 458 nTPM
- white matter: 448 nTPM
- medulla oblongata: 373 nTPM
- thalamus: 352 nTPM
- hypothalamus: 350 nTPM
- pons: 349 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0.58
- gnomAD missense Z
- 1.33
- DepMap mean gene effect
- -0.65
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial humoral response
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cytoplasmic translation
- defense response to Gram-positive bacterium
- innate immune response in mucosa
- translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL39 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL39 as an antibody target. Whether an autoantibody or antibody against RPL39 could matter depends on whether native RPL39 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL39 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL39 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...